Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Durvalumab as consolidation therapy in non-small cell lung cancer: efficacy, safety, and long-term outcomes

2025International Journal of Surgery Global HealthJournalOpen access

10.1097/gh9.0000000000000594 Full text0 citations

Authors

10 authors across 7 institutions in 3 countries.

Emmanuel Nortey-AdomFirst author
as printed: Emmanuel Elorm Nortey-Adom
Israel Charles Abraham
- University of Ilorin (NG)
Sharon Karbo
as printed: Sharon Aa-inir Karbo
Emmanuel Ayanleke
- University of Ilorin (NG)
Ebube Precious Anasiudu
- University of Nigeria (NG)
Olufemi Akinmeji
- Olabisi Onabanjo University (NG)
Olatunji Gbolahan
as printed: Gbolahan Olatunji
Emmanuel Kokori
- University of Ilorin (NG)
S.O. Bukky
as printed: Sulaiman Olaide Bukky
Nicholas AderintoSenior authorCorresponding
- Ladoke Akintola University of Technology (NG)

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Cancer Immunotherapy and Biomarkerslevel 3 · 0.59
Lung Cancer Treatments and Mutationslevel 3 · 0.09
Lung Cancer Diagnosis and Treatmentlevel 3 · 0.05

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 9, 2026
2025 · International Journal of Surgery Global Health · 0 citations
https://openalex.org/W7116884012

Durvalumab as consolidation therapy in non-small cell lung cancer: efficacy, safety, and long-term outcomes · Sankore